To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.

NCT04848662 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BDA MDI (PT027) 160/180 μg
DRUG: Pulmicort Respules 0.5 MG/ML Inhalation Suspension

Sponsor

Bond Avillion 2 Development LP